OFweek Medical Technology Completes: For a long time, 70% of the large-scale high-end medical equipment market such as CT, MRI and PET-CT has been monopolized by three multinational companies such as General Electric, Philips and Siemens. This monopoly pattern is called "GPS myth". It is understood that the current production of Class A medical equipment is very small in China. Before Shanghai Lianying Medical Technology Co., Ltd. launched its own research and development of PET-CT products at the end of last year, no domestic enterprises produced this product. Among the large-scale medical equipments of Class B, only the companies that produce CT, such as Neusoft, Shenzhen Anke, and Shanghai Lianying Medical, have only about 10 companies producing nuclear magnetic resonance. “Domestic companies have a market share of less than 10% in large high-end medical equipment,†Chen Jian said. According to the reporter, the large-scale medical equipment such as PET-CT, the market share of domestic enterprises is almost negligible. The above-mentioned corporate executives analyzed that the current attitude of the national health authorities in piloting some provinces and cities is actually giving a tilt to the allocation of domestic medical equipment, and there is a policy orientation, and there is a possibility of further expanding the pilot. “The health authorities are standing in the perspective of industry management. The procurement of medical equipment is disorderly and still needs to be standardized.†In his view, the configuration license for large medical devices cannot be completely cancelled or released. "If the approval is completely liberalized, the demand of some medical institutions will explode, and the imported equipment does not need to lower the price. In the long run, this will be difficult for domestic manufacturers that are at a disadvantage." He believes that there are certain restrictions on the allocation of imported medical equipment, and the configuration license for domestic production is relatively loose, which is good for domestic manufacturers. "Objectively speaking, if the large-scale medical equipment of Class B is not controlled, some hospitals will purchase excessively and disorderlyly. Class A equipment is basically over 5 million yuan, and relevant departments still need to control it," the executive said. In reality, due to the monopoly of “GPS†on the domestic high-end medical equipment market, the purchase price of large medical equipment is expensive, which ultimately leads to high inspection costs. The price of items such as PET-CT for early detection and diagnosis of major diseases in the fields of tumor, brain and heart is up to 12,000 yuan in some top three hospitals in Beijing, and the price of some top three hospitals in Shanghai is 7,000 yuan. about. The cost of the inspection is not covered by the basic medical insurance reimbursement, and the high price makes many patients discouraged. According to industry insiders, in the past year or so, some of the large-scale medical equipment of "GPS" has been reduced by about 20%, and the possibility of a 15% to 20% reduction in the future. As a result, in the next 2-3 years, the inspection costs of high-end medical projects such as PET-CT are expected to be reduced by 50% on the current basis. Dehydrated Ginger,Dehydrated Ginger For Seasoning,Dehydrated Ginger For Cooking,Dehydrated Ginger For Tea Xinghua Lvwei Foods Co.,Ltd , https://www.lvweifoods.com
Large-scale high-end medical equipment market has long been monopolized>
Next Article
Fruit trees grafted two methods
Prev Article
Water Wong flower prescription